Hengkang Medical Group Co Ltd
SZSE:002219
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.69
3.32
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Hengkang Medical Group Co Ltd
Hengkang Medical Group Co Ltd
PP&E Net
Hengkang Medical Group Co Ltd
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Hengkang Medical Group Co Ltd
SZSE:002219
|
PP&E Net
¥2.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
25%
|
|
|
H
|
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
|
PP&E Net
¥3.1B
|
CAGR 3-Years
31%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
PP&E Net
¥9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
37%
|
CAGR 10-Years
32%
|
|
|
X
|
XiAn International Medical Investment Co Ltd
SZSE:000516
|
PP&E Net
¥8.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
14%
|
CAGR 10-Years
18%
|
|
|
H
|
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
|
PP&E Net
¥1.5B
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sanbo Hospital Management Group Ltd
SZSE:301293
|
PP&E Net
¥769m
|
CAGR 3-Years
43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hengkang Medical Group Co Ltd
Glance View
Hengkang Medical Group Co. Ltd. is engaged in the manufacturing, sale, research and development of traditional Chinese medicines. The company is headquartered in Chengdu, Sichuan and currently employs 7,622 full-time employees. The company went IPO on 2008-03-06. In addition, The Company also engages in the research and development, production and manufacture of Chinese patent medicines, Chinese herbal medicines and Chinese medicinal materials, medical devices, medical institution preparations, daily chemicals and health products. The firm operates its business within the domestic market and overseas markets.
See Also
What is Hengkang Medical Group Co Ltd's PP&E Net?
PP&E Net
2.7B
CNY
Based on the financial report for Sep 30, 2024, Hengkang Medical Group Co Ltd's PP&E Net amounts to 2.7B CNY.
What is Hengkang Medical Group Co Ltd's PP&E Net growth rate?
PP&E Net CAGR 10Y
25%
Over the last year, the PP&E Net growth was 5%. The average annual PP&E Net growth rates for Hengkang Medical Group Co Ltd have been 6% over the past three years , 2% over the past five years , and 25% over the past ten years .
You don't have any saved screeners yet
